ペンシルベニアにおける神経内分泌腫瘍の臨床試験
ペンシルベニア内の拠点で、神経内分泌腫瘍に関する12件の研究が参加者を募集しています。
ペンシルベニア内の都市
公式研究テキスト（英語）
Zanzalintinib Versus Everolimus in Participants With Locally Advanced or Metastatic Neuroendocrine Tumors
- University of Pennsylvania, Philadelphia
- University of Pittsburgh Medical Center (UPMC) Hillman Cancer Center, Pittsburgh
被験者募集中第2/3相
18歳以上 · 全性別 · 2026/09/29更新 · NCT06943755Phase I Trial to Determine the Dose and Evaluate the PK and Safety of Lutetium Lu 177 Edotreotide Therapy in Pediatric Participants With SSTR-positive Tumors
- The Children's Hospital of Philadelphia (CHOP), Philadelphia
被験者募集中第1相
24 Months – 18 Years · 全性別 · 2026/09/25更新 · NCT06441331Carcinoid Syndrome Efficacy Study Featuring an Oral Daily Paltusotine Regimen
- Hospital of the University of Pennsylvania, Philadelphia
被験者募集中第3相
18歳以上 · 全性別 · 2026/09/15更新 · NCT07087054Project: Every Child for Younger Patients With Cancer
- Lehigh Valley Hospital-Cedar Crest, Allentown
- Geisinger Medical Center, Danville
- Penn State Children's Hospital, Hershey
- 他4件
被験者募集中観察研究
25歳以下 · 全性別 · 2026/08/25更新 · NCT02402244A Study to Investigate Safety and Effectiveness of CRN09682 in Participants With SST2-Expressing NENs and Other Solid Tumors
- Crinetics Study Site, Philadelphia
- Crinetics Study Site, Philadelphia
被験者募集中第1/2相
18歳以上 · 全性別 · 2026/07/31更新 · NCT07129252Trial of an Alternative Cabozantinib Dosing Schedule in Metastatic Renal Cell Carcinoma and Neuroendocrine Tumors
- Fox Chase Cancer Center, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/07/28更新 · NCT05263050CapTemY90 for Grade 2/3 NET Liver Metastases
- University of Pennsylvania, Philadelphia
被験者募集中第2相
18歳以上 · 全性別 · 2026/06/04更新 · NCT04339036Dose-defining Study of Tirapazamine Combined With Embolization in Liver Cancer
- University of Pennsylvania, Philadelphia
被験者募集中第1/2相
20歳〜99歳 · 全性別 · 2026/04/20更新 · NCT02174549Study of RYZ101 Compared With SOC in Pts w Inoperable SSTR+ Well-differentiated GEP-NET That Has Progressed Following 177Lu-SSA Therapy
- Research Facility, Pittsburgh
被験者募集中第3相
18歳以上 · 全性別 · 2026/03/30更新 · NCT05477576A Phase 1/2 Study to Evaluate CHM-2101, an Autologous Cadherin 17 Chimeric Antigen Receptor (CAR) T Cell Therapy
- University of Pennsylvania, Philadelphia
被験者募集中第1/2相
18歳〜85歳 · 全性別 · 2026/01/29更新 · NCT06055439Effect on Body Movement and Mental Skills in Patients Who Received Gadolinium-based Contrast Media for Magnetic Resonance Examination Multiple Times Within 5 Years
- Penn State Hershey Medical Center, Hershey
- Albert Einstein Healthcare Network, Philadelphia
被験者募集中第4相
18歳〜64歳 · 全性別 · 2026/01/22更新 · NCT04373564SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
- Massive Bio SYNERGY-AI site, Philadelphia
被験者募集中観察研究
全年齢 · 全性別 · 2025/10/28更新 · NCT03452774ClinicalTrials.govより、2026/10/05時点のデータを取得。各研究には独自の参加資格があり、参加可否は研究チームが決定します。